webinar register page

CDMO Selection for Bispecific Antibody Development: A Case Study Matching Capability to Need

Dec 1, 2020 10:00 AM in Pacific Time (US and Canada)

Webinar logo
* Required information

By registering, I agree to the Privacy Statement and Terms of Service.



Dr. Steven Chamow
Founder & President @Chamow & Associates
Dr. Steven Chamow has over 30 years of experience in biopharmaceutical product development. In his career, he has contributed to the development of four marketed biologics (Avastin, Natrecor, Vectibix and Zadaxin). Dr. Chamow was educated at the University of California (UC Santa Cruz, B.A. in biology; UC Davis, Ph.D. in biochemistry), and completed postdoctoral training at the National Institutes of Health in Bethesda, MD. He is author or co-author of more than 50 scientific publications and patents and co-editor of two books.
Tracy Kinjerski
Global Business Operation Professional @Chamow & Associates
Tracy has over 15 years of experience in the biopharmaceutical industry. She possesses extensive expertise in the biologics CDMO sector, including cell culture, microbial, gene therapy/virology. Tracy has supported business operations as companies transition between business models, delivering revenue growth and profitability for private and publicly traded companies through strategic planning, business operations, financial acumen, industry partnerships and board memberships, marketing, project management, business development, and P&L oversight. Previously, she served as VP, Business Operations at Avid Bioservices where she transitioned the company into a full service CDMO model, successfully impacting corporate profitability in 18 months post-transition. Tracy has also worked in business development roles at AGCBiologics, Fujifilm Diosynth, Althea Technologies and Avecia Biologics. Tracy holds a B.A. Biology, and a M.S. Biomedical Sciences, Molecular Biology.